date/time interval
- April 1, 2017 - March 31, 2021
Small molecules targeting aberrant STAT3 activity: killing breast tumour cells and inducing an anti-tumour immune response.
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
total award amount
- CAD 800646